Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-25

Clinical Trial Update: Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating lenalidomide plus dexamethasone in newly diagnosed POEMS syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Lenalidomide (lenalidomide)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: POEMS Syndrome | Phase 2 | Status: COMPLETED